These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10217098)

  • 21. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B and Hepatocellular Carcinoma.
    Hemming AW; Berumen J; Mekeel K
    Clin Liver Dis; 2016 Nov; 20(4):703-720. PubMed ID: 27742009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects.
    Zaman S; Khan M; Alam K; Williams R
    J Trop Med Hyg; 1995 Feb; 98(1):64-8. PubMed ID: 7861482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk factors of liver tumors].
    Fehér J; Lengyel G
    Orv Hetil; 2004 Feb; 145(7 Suppl 1):365-7. PubMed ID: 15049052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan.
    Kiyosawa K; Furuta S
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S150-6. PubMed ID: 1333901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
    Bréchot C; Minami M; De Mitri S; Paterlini P
    Princess Takamatsu Symp; 1995; 25():199-209. PubMed ID: 8875625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Suwangool P; Mahachai V
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S250-6. PubMed ID: 12929997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M; Ashcavai M; Liew CT; Peters RL
    Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of cytokines in hepatocellular carcinoma.
    Budhu A; Wang XW
    J Leukoc Biol; 2006 Dec; 80(6):1197-213. PubMed ID: 16946019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma and hepatitis C in Mexico.
    Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
    Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of hepatocellular carcinoma.
    Johnson PJ
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma].
    Merle P
    Cancer Radiother; 2005 Nov; 9(6-7):452-7. PubMed ID: 16226912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in HIV positive patients.
    Nunnari G; Berretta M; Pinzone MR; Di Rosa M; Berretta S; Cunsolo G; Malaguarnera M; Cosentino S; De Paoli P; Schnell JM; Cacopardo B
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1257-70. PubMed ID: 23047511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma.
    Manns MP; Kubicka S
    Digestion; 1997; 58 Suppl 1():69-75. PubMed ID: 9225098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.